Eribulin improved overall Survival in patients with HER-2 negative metastatic breast cancer–comparison to bevacizumab plus paclitaxel-. (March 2017)

Record Type:
Journal Article
Title:
Eribulin improved overall Survival in patients with HER-2 negative metastatic breast cancer–comparison to bevacizumab plus paclitaxel-. (March 2017)
Main Title:
Eribulin improved overall Survival in patients with HER-2 negative metastatic breast cancer–comparison to bevacizumab plus paclitaxel-
Authors:
Iwamoto, M.
Kawaguchi, K.
Terasawa, R.
Fujioka, H.
Kimura, K.
Uchiyama, K.
Abstract:
Is Part Of:
Breast. Volume 32(2017)Supplement 1
Journal:
Breast
Issue:
Volume 32(2017)Supplement 1
Issue Display:
Volume 32, Issue 1 (2017)
Year:
2017
Volume:
32
Issue:
1
Issue Sort Value:
2017-0032-0001-0000
Page Start:
S66
Page End:
Publication Date:
2017-03
Subjects:
Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:
http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0960-9776(17)30224-2 ↗
Languages:
English
ISSNs:
0960-9776
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2531.xml